Biocon net surges by 33% to Rs 77 crore - pharmabiz.com PDF Print
pharmabiz.comThe existing verticals in branded formulations (diabetology, oncotherapeutics, nephrology and cardiology) have posted a combined strong YoY growth of 28 per

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.